| Effect of salt substitution on cardiovascular events and death B Neal, Y Wu, X Feng, R Zhang, Y Zhang, J Shi, J Zhang, M Tian, ... New England Journal of Medicine 385 (12), 1067-1077, 2021 | 544 | 2021 |
| Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. J Yu, Z Zhou, RD McEvoy, CS Anderson, A Rodgers, V Perkovic, B Neal JAMA 318 (2), 156-166., 2017 | 409 | 2017 |
| Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia L He, H Zeng, F Li, J Feng, S Liu, J Liu, J Yu, J Mao, T Hong, AF Chen, ... American Journal of Physiology-Endocrinology and Metabolism 299 (6), E1061 …, 2010 | 93 | 2010 |
| Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial J Yu, SR Thout, Q Li, M Tian, M Marklund, C Arnott, MD Huffman, ... The American journal of clinical nutrition 114 (1), 185-193, 2021 | 58 | 2021 |
| High level of source-specific particulate matter air pollution associated with cardiac arrhythmias. WH Baihuan Feng, Xiaoming Song, Mo Dan, Jie Yu, Qiongqiong Wang, Mushui Shu ... Science of The Total Environment. 657, 1285-1293., 2019 | 58 | 2019 |
| Peroxisome Proliferator-Activated Receptor Gamma Agonist Improves Arterial Stiffness in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease J Yu, N Jin, G Wang, F Zhang, J Mao, X Wang Metabolism 56 (10), 1396-1401., 2007 | 53 | 2007 |
| Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis X Yin, A Rodgers, A Perkovic, L Huang, KC Li, J Yu, Y Wu, JHY Wu, ... Heart 108 (20), 1608-1615, 2022 | 49 | 2022 |
| Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis Z Zhou, J Yu, C Carcel, C Delcourt, J Shan, RI Lindley, B Neal, ... BMJ Open 8 (5), e019672., 2018 | 44 | 2018 |
| Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease. J Yu, J Han, J Mao, L Guo, W Gao Chinese Medical Journal 127 (6), 1039-1045., 2014 | 39 | 2014 |
| Cost-effectiveness of a household salt substitution intervention: findings from 20 995 participants of the salt substitute and stroke study KC Li, L Huang, M Tian, GL Di Tanna, J Yu, X Zhang, X Yin, Y Liu, Z Hao, ... Circulation 145 (20), 1534-1541, 2022 | 36 | 2022 |
| Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS). NB Huang L, Tian M, Yu J, Li Q, Liu Y, Yin X, Wu JH, Marklund M, Wu Y, Li N ... Am Heart J. 221, 136-145., 2020 | 30 | 2020 |
| Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial JY Barraclough, J Yu, GA Figtree, V Perkovic, HJL Heerspink, BL Neuen, ... Diabetes, Obesity and Metabolism 24 (6), 1072-1083, 2022 | 29 | 2022 |
| Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Agonist Improves Coronary Artery Endothelial Function in Diabetic Patients with Coronary Artery Disease J Yu, Z Zhang, Z Li, X Feng, L He, S Liu, J Mao, G Wang, X Wang Journal of International Medical Research 38 (1), 86-94., 2010 | 26 | 2010 |
| Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: a systematic review and meta‐analysis C Li, Z Zhou, BL Neuen, J Yu, Y Huang, T Young, J Li, L Li, V Perkovic, ... Diabetes, Obesity and Metabolism 23 (1), 252-257, 2021 | 24 | 2021 |
| Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis C Li, J Yu, C Hockham, V Perkovic, BL Neuen, SV Badve, L Houston, ... Diabetes, Obesity and Metabolism 24 (10), 1927-1938, 2022 | 22 | 2022 |
| Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program J Yu, C Arnott, BL Neuen, HL Heersprink, KW Mahaffey, CP Cannon, ... ESC heart failure 8 (2), 1482-1493, 2021 | 20 | 2021 |
| Coronary flow velocity reserve is improved by PPAR-α agonist fenofibrate in patients with hypertriglyceridemia . WX Wang G, He L, Liu J, Yu J, Feng X, Li F, Hao Y, Mao J, Hong T, Chen AF Cardiovasc Ther. 31 (3), 161-7., 2013 | 20 | 2013 |
| Estimated benefits and risks of using a reduced-sodium, potassium-enriched salt substitute in India: a modeling study M Marklund, F Tullu, S Raj Thout, J Yu, TM Brady, LJ Appel, B Neal, ... Hypertension 79 (10), 2188-2198, 2022 | 18 | 2022 |
| Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial J Yu, J Li, PJ Leaver, C Arnott, MD Huffman, JA Udell, V Perkovic, ... Cardiovascular research 118 (4), 1103-1114, 2022 | 17 | 2022 |
| Low density lipoprotein cholesterol level inversely correlated with coronary flow velocity reserve in patients with Type 2 diabetes J Yu, JL Han, LY He, XH Feng, WH Li, JM Mao, W Gao, G Wang Journal of Geriatric Cardiology: JGC 10 (2), 159-164., 2013 | 16 | 2013 |
Bruce NealUNSW Sydney, Imperial College London,The George Institute for Global Health,University of SydneyVerified email at georgeinstitute.org.au